Elucidating the causal associations underlying Alzheimer's disease
Elucidating the causal associations underlying Alzheimer's disease
批准号:
10335224
负责人:
Shea J Andrews
金额:
$12.32万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-02-01 至 2022-07-01
关键词:
AddressAdvisory CommitteesAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloid beta-ProteinAwardBig Data MethodsBiologicalBlood VesselsCerebrovascular TraumaDementiaDevelopmentDiabetes MellitusDiseaseDisease OutcomeDisease ProgressionEconomic BurdenEducational workshopElderlyElectronic Health RecordEpidemiologyEthicsEtiologyExposure toFeedbackFoundationsGene ExpressionGeneticGenetic Predisposition to DiseaseGenetic VariationGenomicsGenotypeHealthHippocampus (Brain)HypertensionIncidenceIndividualInterventionKnowledgeLeadershipLife StyleLiteratureMendelian randomizationMental DepressionMentorsMethodologyMethodsMinority GroupsMolecularNatureNeurodegenerative DisordersNeurofibrillary TanglesObesityOutcomeParentsPathogenesisPersonsPhasePhenotypePopulationPopulations at RiskPreventionProteinsProxyRandom AllocationRandomized Controlled TrialsResearchResearch PersonnelRiskRisk FactorsSenile PlaquesSmokingSocial isolationSocietiesSubgroupTechniquesTestingTherapeutic InterventionTimeTrainingTraining ProgramsWomanaging populationapolipoprotein E-4basebiobankcase controlcohortdisorder preventionendophenotypeepidemiology studyexperiencegenetic analysisgenetic epidemiologygenetic varianthearing impairmentlifestyle factorslifestyle interventionmodifiable risknoveloffspringphenomephysical inactivitypolygenic risk scorepreventprogramspsychosocialsexskillssuccessful interventionsymposiumtau Proteinstau-1trait
中文摘要
项目摘要
阿尔茨海默病(Alzheimer's disease,AD)是人口老龄化和整个社会面临的全球性危机。数量
在未来几十年中,AD患者预计将急剧增加,因此必须进行研究
旨在降低痴呆症的预期发病率,例如确定生活方式的可改变风险因素,
干预措施。建立生活方式干预措施的先决条件是证明
AD或AD内表型的拟议暴露(风险因素)。这项研究的首要目标是
该计划旨在通过以下方式增强我们对阿尔茨海默病潜在因果关系的理解
利用遗传信息因果推理方法。我们将使用最先进的技术
利用多基因风险评分(PRS)和孟德尔随机化(MR)的统计遗传学
方法。PRS提供了对个体对某一性状的遗传倾向的估计,并可用于推断
通过从一个表型的PRS预测另一个表型的遗传重叠。第一个目标将
通过进行全表型PRS,确定与AD结局具有共同遗传病因的性状
分析.这将优先考虑AD结局的假定疾病修饰性状。第二个目标将进行一次
MR全表型相关性研究,以确定尚未使用
以前的流行病学方法,同时优先考虑当前文献中确定的假设(例如,
血管健康)。MR使用遗传变异作为暴露的代表,以提供因果关系的估计
中间暴露与结果之间的关联,在概念上类似于“遗传”,
由于基因型从亲本到后代的随机分配,因此称为“随机对照试验”。在最后的目标中,
PRS和MR将用于确定个体风险因素是否对AD的发展有不同的贡献
通过进行性别、血统、年龄和APOE ε4分层分析,确定亚组-
具体的风险状况和预测因素。这项拟议的研究将阐明AD的潜在风险因素,
将对预防AD的生活方式干预的发展产生重大影响,并可能解释
性别和血统的风险差异。在他的导师Alison Goate博士和共同导师Dr.
Kristine Yaffe和其他顾问团队,安德鲁斯博士将进行严格的培训计划,
这个奖项的目的,并发展成为一个独立的研究人员。本次培训将重点发展
技能(1)因果推理,(2)大数据分析,(3)计算基因组学,(4)专业
发展在这些领域的发展将通过课程,出席会议
和研讨会,获得提供指导和领导团队的经验,并定期从他的反馈,
咨询委员会。总的来说,拟议的研究解决了一个关键和及时的未满足的需求,
在此期间开发的技能奖励将为候选人建立独立的坚实基础
阿尔茨海默病遗传流行病学的领导地位。
英文摘要
Project Summary
Alzheimer’s disease (AD) is a global crisis facing the aging population and society as a whole. With the number
of people living with AD predicted to rise dramatically in the coming decades, it is imperative to pursue research
that aims to reduce the expected incidence of dementia, such as identifying modifiable risk factors for lifestyle
interventions. A prerequisite to establishing lifestyle interventions is demonstrating a causal effect of the
proposed exposure (a risk factor) on AD or AD endophenotypes. The overarching objective of this research
program is to enhance our understanding of the causal relationships underlying Alzheimer’s disease by
utilizing genetically informed causal inference methods. We will use state-of-the-art techniques in
statistical genetics that exploit the polygenic risk scoring (PRS) and Mendelian randomization (MR)
approaches. PRS provide an estimate of an individual's genetic propensity to a trait and can be used to infer
genetic overlap between phenotypes via predicting one phenotype from the PRS of another. The first aim will
identify traits that have a shared genetic etiology with AD outcomes by conducting a phenome-wide PRS
analysis. This will prioritize putative disease-modifying traits for AD outcomes. The second aim will conduct an
MR phenome-wide association study to identify novel risk factors for AD that have not been identified using
previous epidemiological approaches, while prioritizing hypotheses identified in the current literature (e.g.
vascular health). MR uses genetic variants as proxies for exposures to provide an estimate of the causal
association between an intermediate exposure and an outcome and conceptually similar to a ‘genetic
randomized control trial’ due to the random allocation of genotypes from parents to offspring. In the final aim,
PRS and MR will be used to determine if individual risk factors differentially contribute to the development of AD
in at-risk subgroups by performing sex, ancestry, age, and APOE ε4 stratified analyses to identify subgroup-
specific risk profiles and predictors. The proposed research will elucidate the risk factors underlying AD, which
will have a significant impact on the development of lifestyle interventions to prevent AD and may explain
differences in risk by sex and ancestry. Under the guidance of his mentor Dr. Alison Goate and co-mentor Dr.
Kristine Yaffe, and a team of other advisors, Dr. Andrews will pursue a rigorous training program to accomplish
the aims of this award and to develop into an independent researcher. This training will focus on developing
skills in (1) causal inference, (2) big data analytics, (3) computational genomics, and (4) professional
development. Development in these domains will be accomplished via coursework, attendance at conferences
and workshops, gaining experience in providing mentoring and leading teams, and regular feedback from his
advisory committee. Overall, the proposed study addresses a crucial and timely unmet need, and the additional
skills developed during this award will provide a strong foundation for the candidate to establish independent
leadership in the genetic epidemiology of Alzheimer’s disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.ebiom.2021.103277
发表时间:
2021-03
期刊:
EBioMedicine
影响因子:
11.1
作者:
[Fadista J, Kraven LM, Karjalainen J, Andrews SJ, Geller F, COVID-19 Host Genetics Initiative, Baillie JK, Wain LV, Jenkins RG, Feenstra B]
通讯作者:
Feenstra B
Elucidating the causal associations underlying Alzheimer's disease
-
批准号:10738350
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2021
-
负责人:Shea J Andrews
-
依托单位:
海外基金